204 related articles for article (PubMed ID: 1530022)
1. A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development.
Young RL; Snabes MC; Frank ML; Reilly M
Am J Obstet Gynecol; 1992 Sep; 167(3):678-82. PubMed ID: 1530022
[TBL] [Abstract][Full Text] [Related]
2. Enlarged follicles in women using oral contraceptives.
Broome M; Clayton J; Fotherby K
Contraception; 1995 Jul; 52(1):13-6. PubMed ID: 8521709
[TBL] [Abstract][Full Text] [Related]
3. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
4. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
Masson S; Franssen E; Hilditch JR; Powell MG
Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
Graham CA; Sherwin BB
J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
Weber-Diehl F; Lehnert J; Lachnit U
Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
[TBL] [Abstract][Full Text] [Related]
8. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind trial of two low dose combined oral contraceptives.
Bounds W; Vessey M; Wiggins P
Br J Obstet Gynaecol; 1979 Apr; 86(4):325-9. PubMed ID: 373792
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
[TBL] [Abstract][Full Text] [Related]
15. A comparison of a new graduated estrogen formulation with three constant-dosed oral contraceptives.
Appel TB; Kambi AA; Birdsall C; Christenson DA; Clark DO; DeKoning JR; Dreisbach LA; Frost JF; Gustin AE; Halikis M
Contraception; 1987 Jun; 35(6):523-32. PubMed ID: 3311619
[TBL] [Abstract][Full Text] [Related]
16. Ovarian follicles during oral contraceptive cycles: their potential for ovulation.
Killick SR
Fertil Steril; 1989 Oct; 52(4):580-2. PubMed ID: 2680616
[TBL] [Abstract][Full Text] [Related]
17. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
Ling WY; Johnston DW; Lea RH; Bent AE; Scott JZ; Toews MR
Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
Jain JK; Ota F; Mishell DR
Contraception; 2000 Mar; 61(3):195-8. PubMed ID: 10827333
[TBL] [Abstract][Full Text] [Related]
19. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
20. Cycle control on low-dose oral contraceptives: a comparative trial.
Percival-Smith RK; Yuzpe AA; Desrosiers JA; Rioux JE; Guilbert E
Contraception; 1990 Sep; 42(3):253-62. PubMed ID: 2289388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
